Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

MacRae F Linton

Showing results (151-160 of 208) with videos related to

Pageof 21
Sort By:
The Journal of Clinical Investigation|December 19, 2002
Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosisMasashi Nishida, Hidehiko Fujinaka, Taiji Matsusaka, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2024
Characterizing genetic profiles for high triglyceride levels in U.S. patients of African ancestryLan Jiang, Srushti Gangireddy, Alyson L Dickson, et al.
Frontiers in Physiology|January 27, 2022
Expressing the Human Cholesteryl Ester Transfer Protein Minigene Improves Diet-Induced Fatty Liver and Insulin Resistance in Female MiceLin Zhu, Julia An, Sivaprakasam Chinnarasu, et al.
Journal of the American Heart Association|July 2, 2015
Sex-Specific Parental Effects on Offspring Lipid LevelsIrene M Predazzi, Rafal S Sobota, Serena Sanna, et al.
The Journal of Biological Chemistry|May 2, 2018
Modification by isolevuglandins, highly reactive γ-ketoaldehydes, deleteriously alters high-density lipoprotein structure and functionLinda S May-Zhang, Valery Yermalitsky, Jiansheng Huang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 26, 2019
Lipoprotein modulation of proteinuric renal injuryYohei Tsuchida, Jianyong Zhong, Tadashi Otsuka, et al.
Nature Medicine|June 1, 2001
Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosisLiza Makowski, Jeffrey B Boord, Kazuhisa Maeda, et al.
Biochemical Pharmacology|June 14, 2005
Inhibition of cyclooxygenase with indomethacin phenethylamide reduces atherosclerosis in apoE-null miceMichael E Burleigh, Vladimir R Babaev, Mayur B Patel, et al.
Nature Medicine|October 30, 2025
Author Correction: Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosisLiza Makowski, Jeffrey B Boord, Kazuhisa Maeda, et al.
Journal of the American College of Cardiology|November 13, 2012
Dysfunctional high-density lipoprotein in patients on chronic hemodialysisSuguru Yamamoto, Patricia G Yancey, T Alp Ikizler, et al.
Pageof 21

Showing results (151-160 of 208) with videos related to

Sort By:
Pageof 21
The Journal of Clinical Investigation|December 19, 2002
Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosisMasashi Nishida, Hidehiko Fujinaka, Taiji Matsusaka, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2024
Characterizing genetic profiles for high triglyceride levels in U.S. patients of African ancestryLan Jiang, Srushti Gangireddy, Alyson L Dickson, et al.
Frontiers in Physiology|January 27, 2022
Expressing the Human Cholesteryl Ester Transfer Protein Minigene Improves Diet-Induced Fatty Liver and Insulin Resistance in Female MiceLin Zhu, Julia An, Sivaprakasam Chinnarasu, et al.
Journal of the American Heart Association|July 2, 2015
Sex-Specific Parental Effects on Offspring Lipid LevelsIrene M Predazzi, Rafal S Sobota, Serena Sanna, et al.
The Journal of Biological Chemistry|May 2, 2018
Modification by isolevuglandins, highly reactive γ-ketoaldehydes, deleteriously alters high-density lipoprotein structure and functionLinda S May-Zhang, Valery Yermalitsky, Jiansheng Huang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 26, 2019
Lipoprotein modulation of proteinuric renal injuryYohei Tsuchida, Jianyong Zhong, Tadashi Otsuka, et al.
Nature Medicine|June 1, 2001
Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosisLiza Makowski, Jeffrey B Boord, Kazuhisa Maeda, et al.
Biochemical Pharmacology|June 14, 2005
Inhibition of cyclooxygenase with indomethacin phenethylamide reduces atherosclerosis in apoE-null miceMichael E Burleigh, Vladimir R Babaev, Mayur B Patel, et al.
Nature Medicine|October 30, 2025
Author Correction: Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosisLiza Makowski, Jeffrey B Boord, Kazuhisa Maeda, et al.
Journal of the American College of Cardiology|November 13, 2012
Dysfunctional high-density lipoprotein in patients on chronic hemodialysisSuguru Yamamoto, Patricia G Yancey, T Alp Ikizler, et al.
Pageof 21